Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer

NCT01671332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non Small Cell Lung

Interventions

DRUG: Docetaxel
DRUG: Suramin
DRUG: Docetaxel

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]
[object Object]